BRIEF published on 02/06/2026 at 18:27, 4 months 19 days ago Disclosure of Share Capital and Voting Rights by Edenred Edenred Share Capital Voting Rights French Regulations Financial Disclosure
BRIEF published on 02/06/2026 at 18:27, 4 months 19 days ago Publication du Nombre d’Actions et Droits de Vote d'Edenred au 31 Janvier 2026 Edenred Droits De Vote Actions Finances Janvier 2026
REGULATED PRESS RELEASE published on 02/06/2026 at 18:22, 4 months 19 days ago Disclosure of Share Capital and Voting Rights as of January 31, 2026 Edenred discloses share capital and voting rights as of January 31, 2026, in accordance with French regulations Edenred Share Capital Voting Rights French Regulations
REGULATED PRESS RELEASE published on 02/06/2026 at 18:22, 4 months 19 days ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026 Edenred déclare le nombre d'actions et de droits de vote au 31 janvier 2026, conformément à la réglementation financière en vigueur Edenred Droits De Vote Réglementation Financière Actions Investisseurs
BRIEF published on 01/13/2026 at 16:14, 5 months 12 days ago Bilan Semestriel du Contrat de Liquidité d'Edenred au 31 Décembre 2025 Edenred Contrat De Liquidité Bilan Semestriel Transactions BNP Paribas
BRIEF published on 01/13/2026 at 16:14, 5 months 12 days ago Edenred's Liquidity Contract Report for December 2025 Liquidity Contract BNP Paribas AMF Regulation Trading Volume Shares And Cash
REGULATED PRESS RELEASE published on 01/13/2026 at 16:09, 5 months 12 days ago Half-yearly report relative to the liquidity contract as of December 31, 2025 EDENRED releases half-yearly liquidity contract report with details of shares, cash, and trading volumes. AMF Decision N°2021-01 compliance Edenred Liquidity Contract Investors AMF Decision Trading Volumes
REGULATED PRESS RELEASE published on 01/13/2026 at 16:09, 5 months 12 days ago Bilan semestriel du contrat de liquidité au 31 décembre 2025 Bilan semestriel du contrat de liquidité d'Edenred avec BNP Paribas. Détails des moyens, transactions et volumes échangés au cours du 2ème semestre 2025 Edenred Bilan Semestriel Liquidité AMF BNP Paribas
BRIEF published on 01/08/2026 at 19:35, 5 months 17 days ago Edenred réussit une émission obligataire de 500 millions d'euros Plan Stratégique Emprunt Obligataire Investisseurs Internationaux Refinancement Amélioration Structure Financière
BRIEF published on 01/08/2026 at 19:35, 5 months 17 days ago Edenred Successfully Issues €500 Million Bond Edenred Debt Maturity Investment Corporate Finance Bond Issue
Published on 06/26/2026 at 14:05, 1 hour 6 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 11 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 11 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 26 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 14:00, 1 hour 10 minutes ago Hong Kong celebrates surge of global enterprises driving investment and opportunities
Published on 06/26/2026 at 14:00, 1 hour 10 minutes ago Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
Published on 06/26/2026 at 13:32, 1 hour 38 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 1 hour 40 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 1 hour 40 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 07:00, 8 hours 11 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 11 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
